证券日报网讯 12月11日，东阿阿胶在互动平台回答投资者提问时表示，截至2025年11月10日，公司股 东总数为96750户。 （文章来源：证券日报） ...

证券日报网讯 12月11日，东阿阿胶（000423）在互动平台回答投资者提问时表示，基于当前行业环境 与公司战略等综合考量，保持一定规模的现金储备，是确保公司稳健经营、抵御风险，并把握未来潜在 发展机遇的重要基础。公司将综合考虑行业趋势、市场环境、战略规划及全体股东整体利益，对资金进 行合理配置，切实提升资金使用效率，努力为股东创造长期、稳定且可持续的回报。 ...

Group 1 - The company will maintain a dynamic balance between product sales and prices, with no plans to adjust product prices in the short term [1] - The company aims to develop new products centered around consumer demand, including series like "Ejiao +" and "Ejiao", to explore new business growth points [1] - The focus is on promoting sustainable high-quality development through these initiatives [1] Group 2 - An investor inquired about potential adjustments to the average price of core products by 2025 and the company's strategy preference between maintaining sales and stabilizing prices [3]

根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》等相关规定，现将公司董事会公告回购股份决议的前一个交 易日（2025 年 12 月 4 日）登记在册的前十名股东和前十名无限售条件股东的名 称、持股数量及比例情况公告如下： 证券代码：000423 证券简称：东阿阿胶 公告编号：2025-77 东阿阿胶股份有限公司 关于回购股份事项前十名股东及前十名无限售条件股东 持股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有 虚假记载、误导性陈述或重大遗漏。 东阿阿胶股份有限公司（以下简称"公司"）于 2025 年 12 月 4 日召开第十 一届董事会第十五次会议，审议通过了《关于以集中竞价交易方式回购公司股份 方案的议案》。具体内容，详见公司于 2025 年 12 月 5 日披露在巨潮资讯网 （http://www.cninfo.com.cn）的《关于以集中竞价交易方式回购公司股份方案 的公告》（2025-72）。 注：以上股东的持股数量为合并普通账户和融资融券信用账户后总的持股数量。 三、备查文件 中国证券登记结算有限责任公司深圳分公司出具的股东名册。 ...

证券之星消息，东阿阿胶(000423)12月11日在投资者关系平台上答复投资者关心的问题。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 投资者提问：请问公司高比例分红回馈股东是否写入制度规范。谢谢 东阿阿胶回复：您好！感谢您对公司的关注。公司始终高度重视股东回报，并保持相对稳定且积极的分 红政策。未来，公司将在综合考虑自身经营发展规划、盈利水平、现金流状况以及股东利益等多方面因 素的基础上，有序推进分红政策进一步制度化，以增强回报的稳定性和可预期性。谢谢！ ...

Overview - The aging population in China is driving the rapid rise of the "silver economy," with a strong demand for easy-to-swallow, low-sugar ready-to-eat health products among the elderly, creating a stable consumer group [1] - The health awareness of the general public is increasing, leading to a shift in health maintenance from being exclusive to the elderly to being integrated into the daily lives of younger generations, who are adopting a "light nourishment" concept [1][11] - The ready-to-eat health product market in China is projected to reach a market size of 217.1 billion yuan in 2024, with a year-on-year growth of 10.5% [1][11] Market Characteristics - Common ready-to-eat health products include ready-to-eat donkey-hide gelatin, fresh stewed bird's nest, ready-to-eat ginseng, and others, each targeting different consumer demographics [3][4] - The consumer base for these products has expanded beyond the elderly to include young professionals and health-conscious individuals [7] Development History - Prior to 2000, the market primarily consisted of traditional health ingredients, with the introduction of initial ready-to-eat products occurring in response to consumer demand for convenience [3] - The concept of ready-to-eat health products has evolved significantly since 2016, expanding to include a variety of products that emphasize freshness and natural ingredients [3][4] Market Policies - Recent policies in China emphasize food safety and quality control, requiring strict compliance from ready-to-eat health product manufacturers, thereby promoting industry standardization and high-quality development [6][7] Industry Chain - The industry chain includes suppliers of raw materials, production, and packaging, with a growing focus on meeting the needs of younger consumers and adapting marketing strategies accordingly [7][9] Sales Channels - The online sales channel for ready-to-eat health products is expected to account for 52.8% of the market by 2024, surpassing traditional offline channels [9][10] Competitive Landscape - The market exhibits a varied competitive landscape, with certain segments like ready-to-eat donkey-hide gelatin and fresh stewed bird's nest showing oligopolistic characteristics, while other segments remain fragmented with opportunities for smaller brands [12][13] Future Trends - The industry is expected to continue evolving towards snack-like, convenient forms, with an emphasis on innovative combinations of ingredients to meet specific health needs [14]

Core Insights - The rise of the "warm economy" during winter has led to increased consumer demand for health and wellness products, particularly among younger demographics who prefer convenient and innovative options [1][3][17] - Traditional brands like Dong'e Ejiao are adapting to these trends by launching new product lines that appeal to younger consumers, such as instant Ejiao powder and health snacks [2][8] - New brands like Zhenbu'er are leveraging e-commerce platforms like Douyin to introduce unique products, including the "waterless foot soak" heated boots, catering to fragmented wellness routines [4][5][17] Product Innovation - Dong'e Ejiao has diversified its product offerings beyond traditional forms to include Ejiao dates and cakes, responding to the growing health consciousness among consumers [2][8] - Zhenbu'er has introduced innovative products like the Oolong tea-scented heated neck pillow and the "waterless foot soak" boots, which have gained popularity on Douyin [4][5][17] - Both brands are focusing on creating products that are easy to use and suitable for various consumption scenarios, such as at work or during travel [14][17] E-commerce Strategy - Dong'e Ejiao has successfully expanded its online presence, achieving significant sales through its flagship store on Douyin, with over 440,000 orders recorded [7][8] - Zhenbu'er has also seen impressive sales, with a total exceeding 2.6 million orders across its stores on Douyin [7][8] - The content-driven approach of Douyin e-commerce allows brands to engage consumers effectively, with a focus on storytelling and cultural heritage [9][12][17] Market Trends - The shift towards lighter, more convenient health products reflects changing consumer preferences, particularly among younger generations [14][17] - Both Dong'e Ejiao and Zhenbu'er are targeting the 18-24 age group, with a focus on urban youth and small-town consumers [14][17] - The collaboration between brands and Douyin is fostering a "dual growth" model, where both parties benefit from shared insights and innovations [17]

Core Viewpoint - Dong-E E-Jiao announced a share buyback plan for the first time since its listing in 1996, with a total amount between 100 million and 200 million yuan, aimed at enhancing investor confidence and recognizing the company's intrinsic value [1][2]. Financial Performance - As of September 30, 2025, Dong-E E-Jiao reported total assets of 12.75 billion yuan and equity attributable to shareholders of 9.948 billion yuan, with a liquidity ratio of 9.823 billion yuan [3]. - The planned buyback amount represents only 1.57% of total assets, 2.01% of equity, and 2.04% of current assets [3]. - The company has maintained a high cash dividend policy since its listing, with cumulative dividends reaching 10.03 billion yuan and a consistent payout ratio of nearly 100% in recent years [3]. Revenue and Profit Growth - From 2020 to 2024, Dong-E E-Jiao's revenue grew from 3.409 billion yuan to 5.921 billion yuan, with a compound annual growth rate (CAGR) of 14.7%, while net profit increased from 43 million yuan to 1.557 billion yuan, achieving a CAGR of 187.3% [5]. - For the first three quarters of 2025, the company reported revenue of 4.766 billion yuan and a net profit of 1.274 billion yuan, with a gross margin increase of 3.33 percentage points to 73.69% [5][6]. Research and Development - Dong-E E-Jiao invested 145 million yuan in R&D for the first three quarters of 2025, marking a 62.29% year-on-year increase, with total R&D expenses over the past three years amounting to 492 million yuan [1][6]. - The company has achieved significant R&D milestones, including the development of rapid preparation techniques for traditional products and recognition for its innovative treatments [6]. Strategic Partnerships - Dong-E E-Jiao is collaborating with China Resources Group to explore international markets and invest in a 1 billion yuan pharmaceutical industry fund, focusing on traditional Chinese medicine and synthetic biology [7].

Group 1 - The core viewpoint of the article highlights the technological advancements and digital transformation in Dong'e Ejiao's production processes, showcasing the integration of smart manufacturing and data analytics in traditional industries [1][2] - Dong'e Ejiao has achieved a maximum daily production capacity of 1.5 million bottles through an automated production line, which has improved efficiency by 60% and enhanced the cleanliness and organization of the workspace [1] - The company has implemented smart management in the upstream donkey breeding segment, utilizing intelligent ear tags for real-time monitoring of health data, thereby enhancing the overall efficiency of the supply chain [1] Group 2 - Dong'e County is focusing on nurturing high-quality enterprises, establishing a cultivation database for small and medium-sized enterprises based on their scale, innovation capability, and market competitiveness [2] - In 2023, Dong'e County has organized 30 enterprises to apply for high-tech enterprise status, with Dong'e Ejiao being recognized as one of the first batch of exemplary intelligent factories in China [2] - The high-tech industry in Dong'e County has seen a growth rate of 13.85% from January to October, with its output value accounting for 72.09% of the total industrial output [2] Group 3 - There is an ongoing effort to strengthen university-industry collaboration, with 26 agreements signed between local universities and enterprises, including partnerships with renowned academic teams [3] - The establishment of the Liaocheng University Dong'e Industry Technology Research Institute and recognition of Aorun Pharmaceutical as a provincial postdoctoral innovation practice base indicate a commitment to fostering innovation and talent development [3] - The integration of talent cultivation with industry needs is being emphasized, with the addition of a new Taishan industry leader and a project selected for a national talent program [3]

编辑 杨娟娟 新京报贝壳财经讯 12月4日，东阿阿胶发布公告称，基于对未来发展的信心和对公司内在价值的认可， 为维护广大投资者利益、增强投资者信心，进一步提升公司价值，在考虑经营情况和财务状况的基础 上，公司拟以自有资金通过二级市场回购公司股份，拟回购金额不超过2亿元（含），不低于1亿元 （含）。本次回购股份将用于注销并减少公司注册资本。 ...